Quarterly report pursuant to Section 13 or 15(d)

Note 9. Segment and Geographic Information

v2.4.0.6
Note 9. Segment and Geographic Information
 9 Months Ended
Dec. 31, 2011
Segment Reporting Disclosure [Text Block]
Note 9. Segment and Geographic Information

The Company generates revenues from wound care products which are sold into the human and animal health care markets and the Company generates revenues from laboratory testing services which are provided to medical device manufacturers. The Company operates a single segment business which consists of three geographical sales territories as follows (in thousands):

   
Three Months
   
Nine Months
 
   
Ended
   
Ended
 
   
December 31,
   
December 31,
 
   
2011
   
2010
   
2011
   
2010
 
U.S.
 
$
1,005
   
$
477
   
$
3,291
   
$
1,915
 
Mexico
   
1,168
     
1,082
     
3,852
     
3,135
 
Europe and Other
   
424
     
444
     
1,554
     
1,280
 
   
$
2,597
   
$
2,003
   
$
8,697
   
$
6,330
 

The Company’s service revenues amounted to $193,000 and $310,000 for the three months ended December 31, 2011 and 2010, respectively. The Company’s service revenues amounted to $696,000 and $713,000 for the nine months ended December 31, 2011 and 2010, respectively.